News
Scroll through our latest news and be the first to know about important developments
How does cell‐based non‐invasive prenatal test (NIPT) perform against chorionic villus sampling and cell‐free NIPT in detecting trisomies and copy number variations? A clinical study from Denmark
Abstract Objectives: We aimed to compare cell‐based NIPT (cbNIPT) to chorionic villus sampling (CVS) and to examine the test characteristics of cbNIPT in the first
Diagnosis of hydatidiform moles using circulating gestational trophoblasts isolated from maternal blood
Introduction: Identifying hydatidiform moles (HMs) is crucial due to the risk of gestationaltrophoblastic neoplasia. When a HM is suspected on clinical findings, surgical termination isrecommended.
Noninvasive prenatal screening for cystic fibrosis using circulating trophoblasts: Detection of the 50 most common disease‐causing variants
Objectives: Cystic fibrosis (CF) is one of the most common severe autosomal recessive disorders. Prenatal or preconception CF screening is offered in some countries. A
Remembering Steen
We pay tribute to Prof. Steen Kølvraa, one of the founders of ARCEDI Bitoech, and a pioneer in the fetal cell research in Denmark, who passed away six years ago on 31st March 2016.
ARCEDI featured by Danish Ministry
ARCEDI’s fetal cell-based noninvasive prenatal technology gets featured in a video by the Ministry of Industry, Business and Financial Affairs, Denmark.
Cell-Based NIPT Detects 47,XXY Genotype in a Twin Pregnancy
Background: The existing risk of procedure-related miscarriage following invasive sampling for prenatal diagnosis is higher for twin pregnancies and some women are reluctant to test
